Announcements Trials

Browse Landscape

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × ribociclib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 36 Neoplasm Metastasis 5 Neoplasms 3 Neoplasms by Site 2 Melanoma 2 Hereditary Sensory and Autonomic Neuropathies 2 Glioblastoma 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Diseases 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Recurrence 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Meningioma 1 Lung Neoplasms 1 Locoregional Recurrence 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 Head and Neck Neoplasms 1 HR+/HER2- Breast Cancer 1 HER2 Negative Breast Cancer Not Immediately Operated 1 Glioma 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 ER+ HER2- Advanced Breast Cancer 1 Digestive System Neoplasms 1

Interventions

fludarabine 3 Etoposide 3 Cyclophosphamide 3 Carboplatin 3 fludarabine phosphate 2 Sirolimus 2 Paclitaxel 2 Cisplatin 2 tremelimumab 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 lutetium Lu 177 dotatate 1 etoposide phosphate 1 durvalumab 1 Vorinostat 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1 Respiratory Physiological Phenomena 1 Proton Therapy 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡